BioCellgraft - BioCellgraft specializes in regenerative health therapies specifically designed to enhance soft and hard tissue regeneration within the oral cavity. Our flagship product, OraFyl, is a highly purified biological matrix derived from the chorionic portion of the human placenta (HPCTM - Human Placenta Connective Tissue Matrix). It consists of native collagen and elastin presented in their most purified molecular scaffold form.

BioCellgraft specializes in regenerative health therapies specifically designed to enhance soft and hard tissue regeneration within the oral cavity. Our flagship product, OraFyl, is a highly purified biological matrix derived from the chorionic portion of the human placenta (HPCTM - Human Placenta Connective Tissue Matrix). It consists of native collagen and elastin presented in their most purified molecular scaffold form.

Blog

February 15, 2024March 19, 2024

My Fellows on the Battlefield

Welcome to BioCellgraft Inc. Our company was founded b...

January 23, 2024January 23, 2024

A decellularized flowable placental connective tissue matrix supports cellular functions of human tenocytes in vitro

PurposeInjectable connective tissue matrices (CTMs) ma...

January 22, 2024January 22, 2024

BioCellgraft Celularity Partnership

BioCellgraft, Inc. has become the pioneering company paving the way for human connective tissue matrix (HCTM) regenerative therapies with a proven product portfolio designed to effectively treat unmet oral healthcare conditions

Previous page 1 2 3 4